Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00884117 · ClinicalTrials.gov registry record
Influenza Resistance Information Study
A clinical trial, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 4,561
- Enrollment target
NCT00884117 is a clinical trial that has completed, run by Hoffmann-La Roche. The registered enrollment target is 4,561 participants.
The verdict
NCT00884117 has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 4,561 participants
- Enrollment target
Study Summary
This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and susceptibility. Participants clinically diagnosed with influenza will undergo a rapid diagnostic test and viral sampling at Baseline and on Days 3, 6, and 10. Participants will be clinically managed according to local guidelines and the decision to treat/not treat will be at the discretion of the Investigator.
Interventions
- DRUG Oseltamivir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,561 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00884117
The ClinicalTrials.gov registry entry for NCT00884117 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,561 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oseltamivir is the first listed.
NCT00884117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00884117 about?
NCT00884117 is a clinical study titled "Influenza Resistance Information Study". This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and susceptibility. Participants clinically diagnosed with influenza will undergo a rapid diagnostic test and v...
What is the current status of trial NCT00884117?
This trial is currently completed. The enrollment target is 4,561 participants. The study started on 2009-01. Estimated completion is 2015-11.
What interventions are being tested in trial NCT00884117?
The interventions under investigation include: Oseltamivir (DRUG).
Who is sponsoring clinical trial NCT00884117?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.